December 29, 2003
BD Names Jeffrey S. Sherman Vice President and General Counsel
|
December 02, 2003
BD to Present at Merrill Lynch Medical Technology University Conference
|
November 24, 2003
BD Board Declares Dividend Increase of 50%
|
November 06, 2003
BD Announces Record Fiscal Fourth Quarter and Full Year Revenues
|
November 06, 2003
BD Applauds Senate Action To Prevent Unsafe Medical Practices That Can Cause HIV/AIDS Spread In Africa
|
November 05, 2003
BD to Present at Credit Suisse First Boston's Health Care Conference
|
November 05, 2003
BD to Announce Fourth Fiscal Quarter and Year-End Results
|
November 04, 2003
BD to Present at the CIBC World Markets Fourteenth Annual Healthcare Conference
|
October 30, 2003
BD Supplemental Statement Regarding Voluntary Recall of BD ProbeTec™ ET Instrument
|
October 29, 2003
BD Introduces New BD Ultra-Fine™ II, Thinnest Insulin Syringe Needle Available In US
|
October 07, 2003
Park City Solutions Joins BD to Co-Market BD.id™ Patient Identification System
|
September 04, 2003
BD to Present at the Bear Stearns 16th Annual Healthcare Conference
|
August 29, 2003
BD to Present at Thomas Weisel Partners Healthcare Tailwinds 2003 Conference
|
August 22, 2003
BD Statement Regarding Voluntary National Recall of BD ProbeTec™ ET Instrument
|
July 31, 2003
BD to Present at Adams, Harkness & Hill 23rd Annual Summer Seminar
|
July 24, 2003
BD Announces Results for Fiscal Third Quarter
|
July 22, 2003
BD Board Declares Dividend
|
June 30, 2003
BD to Announce Third Fiscal Quarter Results
|
June 05, 2003
BD to Present at Goldman Sachs Twenty Fourth Annual Global Healthcare Conference
|
May 20, 2003
BD Board Declares Dividend
|
May 01, 2003
BD to Present at the 2003 Deutsche Bank Securities Health Care Conference
|
April 25, 2003
BD Announces Fiscal Second Quarter Results
|
April 25, 2003
Webcast Replay - BD 2Q Earnings Conference Call, April 25, 2003, 8:30 AM ET
|
April 24, 2003
BD to Present at Morgan Stanley 1st Annual Healthcare Unplugged Conference
|
April 22, 2003
Edward F. DeGraan Elected to BD Board of Directors
|
April 16, 2003
BD Announces Plans for Discontinuation of Conventional Needle Sales in US Across Many Product Categories
|
April 15, 2003
BD CEO Edward J. Ludwig Selected to Serve on US-Japan Private Sector / Government Commission
|
April 02, 2003
BD to Announce Second Fiscal Quarter Results
|
March 18, 2003
BD to Present at the SG Cowen 23rd Annual Health Care Conference
|
March 14, 2003
BD Names Vincent A. Forlenza President of BD Biosciences
|
February 05, 2003
BD Comments Further on West Pharmaceutical Services Plant Incident
|
February 03, 2003
BD to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference
|
January 29, 2003
BD Statement in Response to West Pharmaceutical Services Plant Incident
|
January 28, 2003
BD Board Authorizes Additional Share Repurchases
|
January 28, 2003
BD Board Declares Dividend
|
January 23, 2003
BD Announces Results for Fiscal First Quarter
|
January 16, 2003
BD to Announce First Fiscal Quarter Results
|
January 08, 2003
BD Presents New Blood Glucose Monitoring Products and Announces Strategic Relationships with Medtronic MiniMed and Eli Lilly and Company
|
January 08, 2003
BD Introduces New Systems to Make Diabetes Monitoring and Management Easier, Faster, and Less Painful
|
